Hybrid Intelligence & Empirical Stability Framework (HIESF)

ENFORMIS: The Computational CMC Foundry

The first regulatory-grade computational platform for formulation intelligence, solid-state stability, and dissolution kinetics. Accelerating drug product development by up to 94% - from molecule to manufacturing without the wet-lab empirical bottleneck.

Regulatory Compliance: FDA 2026 & EU AI ActCore Mathematics: PINNs, Arrhenius ODEs, Heckel MechanicsEmpirical Validation: 106 Seed APIs

Compress 12 Months to 12 Seconds

Waiting 6 to 12 months for physical ICH stability chamber readouts forces R&D into a crawl. Enformis screens hundreds of excipient and polymer matrices in seconds.

Zero Non-Physical Hallucinations

By embedding Fick's Second Law directly into Physics-Informed Neural Network (PINN) loss functions, the engine eliminates ungrounded guesses and impossible "self-healing" compounds.

Glass-Box Regulatory Immunity

Preempting the EU AI Act (August 2026 enforcement) and FDA computational guidelines. Glass-box Explainable Boosting Machines (EBMs) provide complete mathematical receipts for filings.

Active Kinetic Simulations

Enformis Dual-Engine Live Biophysical Visualizers

Observe the continuous differential kinetic solvers and physics-informed dissolution dynamics running in real-time.

The Virtual Oven: Arrhenius Kinetics & SMARTS Hazard Profiler (Enformis™)
Kinase Inhibitor Form B (ICH Accelerated Chamber)
Continuous ODE Solver (k = A e^-Ea/RT)
Condition: 40°C / 75% RH (ICH Accelerated)Predicted Shelf-Life: 38.4 Months
Physics-Informed Neural Dissolution & Heckel Compaction (PINN)
Amorphous Solid Dispersion (HPMC-AS Matrix)
Fickian Diffusion Constraint (L_phys → 0)
Similarity Factor: 78.4 (Pass: >50)PINN Physics Loss: 0.0031 (Physically Bound)
Solid-State Crystalline Habit & Excipient Packing (Enformis™)
Enformis™ Monoclinic P2₁/c Co-Crystal Packing Lattice
Monoclinic P2₁/c Co-Crystal LatticeThermal Degradation: Tonset = 214.6°C (ICH Q1A Stable)
Heckel Powder Compaction Mechanics (Module 4B)
ln(1 / 1-D) = K·P + A
Rotary Tableting Press ToolingMechanical Integrity: Zero Capping / Plastic Yield Yield K = 0.0084
Modular Scientific Architecture

The 5 Sequential Computational Modules

Engineered across first-principles quantum chemistry, continuum thermodynamics, and clinical pharmacokinetics.

MODULE 01Team Alpha

API Profiler & Quantum BDE

DFT, ALFABET, Graph Embeddings

Ingests raw SMILES and computes quantum-mechanical bond dissociation energies (BDE) and frontier molecular orbital distributions (HOMO-LUMO gap), pinpointing exactly which covalent bonds will cleave first under thermal or oxidative stress.

Deliverables:
Atom-level bond cleavage vulnerabilities, pKa profiles, BCS Class determination.
MODULE 02Team Beta

Excipient Matrix Matchmaker

Flory-Huggins (χ), Gordon-Taylor (Tg)

Simulates polymer compatibility and thermodynamic miscibility across Amorphous Solid Dispersions (ASDs), Orodispersible Films (ODFs), and Lipid Nanoparticles (LNPs). Programmatically flags reactive incompatibilities (Maillard browning, ester transesterification, peroxide radical attack).

Deliverables:
Excipient compatibility matrix, phase separation risk (T - Tg ≥ Δ).
MODULE 03Team Gamma

Virtual Manufacturing Line

Mass Transport, WVTR, OTR Sorption

Models environmental micro-stresses during compaction, mixing shear, and packaging storage. Calculates moisture ingress through container-closure barriers based on packaging Water Vapor Transmission Rate (WVTR) and Oxygen Transmission Rate (OTR).

Deliverables:
Compaction dwell curves, barrier packaging specifications, container surface loss.
MODULE 04ATeam Delta (Stability)

The Virtual Oven (Stability Engine)

Arrhenius ODEs, Right-Censored Weibull

40+ topological SMARTS hazard queries combined with continuous Arrhenius differential equations and Henderson-Hasselbalch ionization speciation. Calculates exact time to 10% degradation (t90) and Beyond-Use Dating (BUD) without 6 months of chamber aging.

Deliverables:
Degradation kinetics k = A e^-Ea/RT, t90 shelf-life, Greenwood confidence intervals.
MODULE 04BTeam Delta (Performance)

The Virtual Press & Stomach (Dissolution)

Heckel Compaction, Noyes-Whitney PINNs

Maps powder compaction pressure (P) to relative density (D) via the Heckel equation, flagging capping and lamination. Solves Noyes-Whitney dissolution via Physics-Informed Neural Networks (PINNs) constrained by Fick's Second Law with Matérn 5/2 GP confidence bands.

Deliverables:
Dissolution similarity (f2 > 50), compaction limits, zero-hallucination PINN loss.
MODULE 05Team Epsilon

PBPK & Clinical Bioavailability

Level A IVIVC, Gastrointestinal ODEs

Translates in-vitro dissolution profiles and degradation kinetics into in-vivo human pharmacokinetics. Multi-compartment transit ODEs predict human plasma concentration curves, peak plasma concentration (Cmax), and area under the curve (AUC).

Deliverables:
In Vitro-In Vivo Correlation (IVIVC), human exposure curves, therapeutic window verification.
GxP Decision Arbiter & Quality Gate

"Saying 'I Don't Know' is a Feature, Not a Failure."

In hospital compounding and clinical manufacturing, an over-estimated shelf-life delivers sub-potent or toxic medicine to patients. Enformis implements a mandatory 5-point veto gate: if any check fails, the beyond-use dates are completely withheld rather than generating an ungrounded hallucination.

Destructive Withholding Protocol:
System withholds 91% of out-of-domain queries, ensuring clinical and regulatory zero-liability.

The 5-Point Veto Applicability Checks:

01
Corpus Provenance:Fails if training data is based on unverified literature or uncalibrated synthetic data.
02
Structural Coverage:Fails if molecular Tanimoto fingerprint similarity to known chemical analogs is below 0.40.
03
Condition Coverage:Fails if queried conditions fall >5°C or >0.5 pH outside verified empirical ranges.
04
Statistical Support:Fails if Kish Effective Sample Size (ESS) is < 3 or historical failure events are < 2.
05
Model Coherence:Fails if Kaplan-Meier survival, Weibull MLE, and Arrhenius estimators diverge by > 10x.
Project 360 Dossier Integration

The Missing Scientific Half of Pharmaceutical Due Diligence

Project 360 Dossier evaluates biology, patent thickets, and competitive landscapes. Enformis plugs directly into the pipeline to evaluate CMC and formulation feasibility. You now receive an unassailable unified assessment: “This target is biologically validated, the IP is cleared, and the physical drug product can be stably manufactured.”